Literature DB >> 19856229

Hoyeraal-Hreidarsson syndrome: magnetic resonance imaging findings.

Shigeko Kuwashima1.   

Abstract

Hoyeraal-Hreidarsson syndrome (HH) has been defined as a severe variant of dyskeratosis congenita (DKC). We report here a case of a 6-year-old girl with HH who presented with bone marrow hypoplasia, skin pigmentation, nail dystrophy, growth retardation, and bilateral retinal hemorrhage. Brain MRI revealed cerebellar hypoplasia, hypoplasia of the corpus callosum, a small pituitary gland, a small brain stem, and focal long T2 lesions in the thalamus and brain stem. A brain computed tomography scan revealed intracranial calcification as well. To the best of our knowledge, a small pituitary gland and focal long T2 lesions in the thalamus and brain stem have never been reported as a feature of HH.

Entities:  

Mesh:

Year:  2009        PMID: 19856229     DOI: 10.1007/s11604-009-0344-1

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  9 in total

1.  Peripheral neuropathy--a novel finding in dyskeratosis congenita.

Authors:  Patrick Ip; Ravi Knight; Inderjeet Dokal; Adnan Y Manzur; Francesco Muntoni
Journal:  Eur J Paediatr Neurol       Date:  2005       Impact factor: 3.140

2.  Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.

Authors:  Tom J Vulliamy; Anna Marrone; Stuart W Knight; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

3.  Height of normal pituitary gland on MR imaging: age and sex differentiation.

Authors:  M Suzuki; T Takashima; M Kadoya; H Konishi; T Kameyama; J Yoshikawa; T Gabata; K Arai; S Tamura; T Yamamoto
Journal:  J Comput Assist Tomogr       Date:  1990 Jan-Feb       Impact factor: 1.826

4.  Congenital hypoplastic thrombocytopenia and cerebral malformations in two brothers.

Authors:  H M Hoyeraal; J Lamvik; P J Moe
Journal:  Acta Paediatr Scand       Date:  1970-03

Review 5.  A case of Høyeraal-Hreidarsson syndrome: delayed myelination and hypoplasia of corpus callosum are other important signs.

Authors:  S Akaboshi; M Yoshimura; T Hara; H Kageyama; K Nishikwa; T Kawakami; A Ieshima; K Takeshita
Journal:  Neuropediatrics       Date:  2000-06       Impact factor: 1.947

6.  The neuroradiological findings in a case of Revesz syndrome.

Authors:  Meir H Scheinfeld; Yvonne W Lui; Edward A Kolb; Harry M Engel; William A Gomes; Karen M Weidenheim; Jacqueline A Bello
Journal:  Pediatr Radiol       Date:  2007-09-14

Review 7.  Dyskeratosis congenita: a genetic disorder of many faces.

Authors:  M Kirwan; I Dokal
Journal:  Clin Genet       Date:  2007-11-14       Impact factor: 4.438

8.  A syndrome of progressive pancytopenia with microcephaly, cerebellar hypoplasia and growth failure.

Authors:  S Hreidarsson; K Kristjansson; G Johannesson; J H Johannsson
Journal:  Acta Paediatr Scand       Date:  1988-09

Review 9.  Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome).

Authors:  Yves Sznajer; Clarisse Baumann; Albert David; Hubert Journel; Didier Lacombe; Yves Perel; Pascale Blouin; Jean-François Segura; Jean-Pierre Cezard; Michel Peuchmaur; Tomy Vulliamy; Inderjeet Dokal; Alain Verloes
Journal:  Eur J Pediatr       Date:  2003-09-30       Impact factor: 3.183

  9 in total
  3 in total

Review 1.  X-linked disorders with cerebellar dysgenesis.

Authors:  Ginevra Zanni; Enrico S Bertini
Journal:  Orphanet J Rare Dis       Date:  2011-05-15       Impact factor: 4.123

Review 2.  Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder.

Authors:  Galina Glousker; Fabien Touzot; Patrick Revy; Yehuda Tzfati; Sharon A Savage
Journal:  Br J Haematol       Date:  2015-05-04       Impact factor: 6.998

3.  Brain imaging features of children with Hoyeraal-Hreidarsson syndrome.

Authors:  Ming-Jie Zhang; Ya-Xian Cao; Hui-Ying Wu; He-Hong Li
Journal:  Brain Behav       Date:  2021-03-18       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.